Recent insights on nanomedicine for augmented infection control

References

• KalhapureRSSulemanNMocktarCSeedatNGovenderTNano-engineered drug delivery systems for enhancing antibiotic therapyJ Pharm Sci201510487290510.1002/jps.2429825546108
   PubMed Web of Science ®Google Scholar
• FukushimaKPrattRCNederbergFOrganocatalytic approach to amphiphilic comb-block copolymers capable of stereocomplexation and self-assemblyBiomacromolecules200993051305610.1021/bm800526k
   Google Scholar
• JoYKKimBHJungGAntifungal activity of silver ions and nanoparticles on phytopathogenic fungiPlant Dis2009931037104310.1094/PDIS-93-10-103730754381
   PubMed Web of Science ®Google Scholar
• HussainASinghSKEvidences for anti-mycobacterium activities of lipids and surfactantsWorld J Microbiol Biotechnol201632E710.1007/s11274-015-1965-4
   PubMedGoogle Scholar
• GouldIBalANew antibiotic agents in the pipeline and how they can help overcome microbial resistanceVirulence2013418519110.4161/viru.2453023302792
   PubMed Web of Science ®Google Scholar
• AllahverdiyevAMAbamorESBagirovaMRafailovichMAntimicrobial effects of TiO2 and Ag2O NPs against drug-resistant bacteria and leishmania parasitesFuture Microbiol2011693394010.2217/fmb.11.7821861623
   PubMed Web of Science ®Google Scholar
• MalarkodiCKumarRSPaulkumarVMGnanajobithaGAnnaduraiGBiosynthesis and antimicrobial activity of semiconductor NPs against oral pathogensBioinorg Chem Appl201410.1155/2014/347167
   Google Scholar
• BuzeaCPachecoIIRobbieKNanomaterials and nanoparticles: sources and toxicityBiointerphases20072177110.1116/1.2815690
   Web of Science ®Google Scholar
• HussainASamadASinghSKAhsanMNFarukAAhmadFJEnhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin BDrug Develop Ind Pharm20154178079010.3109/03639045.2014.902957
   PubMed Web of Science ®Google Scholar
• KondoEKanaiKFurther studies on the lethal effect of long chain fatty acids on MycobacteriaJapan J Med Sci Biol197629253710.7883/yoken1952.29.25785063
   PubMedGoogle Scholar
• ZareiMJamnejadAKhajehaliEAntibacterial effect of silver nanoparticless against four foodborne pathogensJundishapur J Microbiol20147E872010.5812/jjm.872025147658
   PubMed Web of Science ®Google Scholar
• CuiYZhaoYTianYZhangWLüXJiangXThe molecular mechanism of action of bactericidal gold NPs on Escherichia coliBio-materials2012332327233310.1016/j.biomaterials.2011.11.057
   Google Scholar
• LimaEGuerraRLaraVGuzmánAGold nanoparticles as efficient antimicrobial agents for Escherichia coli and Salmonella typhiChem Cent J20137E1110.1186/1752-153X-7-11
   PubMed Web of Science ®Google Scholar
• LeungYHNgAXuXMechanisms of antibacterial activity of MgO: non-ROS mediated toxicity of MgO nanoparticles towards Escherichia coliSmall2014101171118310.1002/smll.20130218824344000
   PubMed Web of Science ®Google Scholar
• JeongMSParkJSSongSHJangSBCharacterization of antibacterial NPs fromthe scallop, Ptinopecten yessoensisBiosci Biotechnol Biochem2007712242224710.1271/bbb.7022817827678
   PubMed Web of Science ®Google Scholar
• VidicJStankicSHaqueFSelective antibacterial effects of mixed ZnMgO nanoparticlesJ Nanoparticle Res20131511010.1007/s11051-013-1595-4
   Web of Science ®Google Scholar
• QianYYaoJRusselMChenKWangXCharacterization of green synthesized nano-formulation (ZnO–Avera) and their antibacterial activity against pathogensEnv Toxicol Pharmacol20153973674610.1016/j.etap.2015.01.01525723342
   PubMed Web of Science ®Google Scholar
• MoghimiRGhaderiLRafatiHAliahmadiAMcClementsDJSuperior antibacterial activity of nanoemulsion of Thymus daenensis essential oil against E. coliFood Chem201619441041510.1016/j.foodchem.2015.07.13926471573
   PubMed Web of Science ®Google Scholar
• SinghNVermaSMSinghSKVermaPRPEvidence for bactericidal activities of lipidic nanoemulsions against Pseudomonas aeroginosaAnton Van Leeuwen20151071555156810.1007/s10482-015-0449-8
   PubMed Web of Science ®Google Scholar
• GrayKCPalaciosDSDaileyIAmphotericin primarily kills yeast by simply binding ergosterolProc Natl Acad Sci U S A20121092234223910.1073/pnas.111728010922308411
   PubMed Web of Science ®Google Scholar
• Luengo-AlonsoCTorradoJJBallesterosMPA novel performing PEG-cholane nanoformulation for amphotericin B deliveryInt J Pharm2015495415110.1016/j.ijpharm.2015.08.07026319629
   PubMedGoogle Scholar
• CaldeiraLRFernandesFRCostaDFFrezardFAfonsoCCFerreiraLMNanoemulsions loaded with amphotericin B: a new approach for the treatment of leishmaniasisEur J Pharm Sci20157012513110.1016/j.ejps.2015.01.01525660615
   PubMed Web of Science ®Google Scholar
• GilliganPHMicrobiology of airway disease in patients with cystic fibrosisClin Microbiol Rev1991435511900735
   PubMed Web of Science ®Google Scholar
• BargoniACavalliRZaraGPFundaroACaputoOGascoMRTransmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II – tissue distributionPharm Res200143497502
   Web of Science ®Google Scholar
• MosqueiraVCLoiseauPMBoriesCLegrandPDevissaguetJPBarrattGEfficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected miceAntimicrob Agents Chemother2004481222122815047523
   PubMed Web of Science ®Google Scholar
• AhmadZPandeyRSharmaSKhullerGKAlginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potentialInd J Chest Dis Allied Sci200648171176
   PubMedGoogle Scholar
• PandeyRKhullerGKOral nanoparticle-based antituberculosis drug delivery to the brain in an experimental modelJ Antimicrob Chemother2006571146115210.1093/jac/dkl12816597631
   PubMed Web of Science ®Google Scholar
• EspuelasMSLegrandPCampaneroMAPolymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic effi-cacy against systemic candidiasis in neutropenic miceJ Antimicrob Chemother20035241942710.1093/jac/dkg35112888593
   PubMed Web of Science ®Google Scholar
• TyagiRLalaSVermaAKTargeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasisJ Drug Target20051316117110.1080/1061186050004673216036304
   PubMed Web of Science ®Google Scholar
• PandeyRKhullerGKSolid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosisTuberculosis20058522723410.1016/j.tube.2004.11.00315922668
   PubMed Web of Science ®Google Scholar
• CavalliRGascoMRChetoniPBurgalassiSSaettoneMFSolid lipid nanoparticles (SLN) as ocular delivery system for tobramycinInt J Pharm200223824124511996827
   PubMed Web of Science ®Google Scholar
• SoutoEBWissingSABarbosaCMMullerRHDevelopment of a controlled release formulation based on SLN and NLC for topical clotrimazole deliveryInt J Pharm2004278717710.1016/j.ijpharm.2004.02.03215158950
   PubMed Web of Science ®Google Scholar
• GuptaMVyasSPDevelopment, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasisChem Phys Lipids201216545446110.1016/j.chemphyslip.2012.01.00622309657
   PubMed Web of Science ®Google Scholar
• AhmedMRamadanWRambhuDShakeelFPotential of nanoemulsions for intravenous delivery of rifampicinPharmazie20086380681119069240
   PubMed Web of Science ®Google Scholar
• GangadharamPRAshtekarDAGhoriNGoldsteinJADebsRJDuzgunesNChemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige miceJ Antimicrob Chemother1991284254351960123
   PubMed Web of Science ®Google Scholar
• FieldingRMLewisROMoon-McDermottLAltered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome)Pharm Res199815177517819834002
   PubMed Web of Science ®Google Scholar
• OnyejiCONightingaleCHMarangosMNEnhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplaninInfection19942233834210.1007/BF017155427843812
   PubMed Web of Science ®Google Scholar
• SchiffelersRStormGBakker-WoudenbergILiposome encapsulated aminoglycosides in pre-clinical and clinical studiesJ Antimicrob Chemother20014833334411532996
   PubMed Web of Science ®Google Scholar
• OmriASuntresZEShekPNEnhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infectionBiochem Pharmacol2002641407141312392822
   PubMed Web of Science ®Google Scholar
• TakemotoKYamamotoYUedaYSumitaYYoshidaKNikiYComparative studies on the efficacy of AmBisome and Fungizone in a mouse model of disseminated aspergillosisJ Antimicrob Chemother20045331131710.1093/jac/dkh05514729753
   PubMed Web of Science ®Google Scholar
• KimJSKimHKChungHSohnYTKwonICJeongSYDrug formulations that form a dispersed cubic phase when mixed with waterProc Int Symp Control Rel Bioact Mater20002711181119
   Google Scholar
• JainSYadavPSwamiRSwarnakarNKKushwahVKatiyarSSLyotropic liquid crystalline nanoparticles of amphoteriicn B: implication of pytantriol glyceryl monooleate on bioavailability enhancementAAPS PharmSciTech20181941699171129532426
   PubMedGoogle Scholar
• SilvaMRicelliNLSeoudOEPotential tuberculostatic agent: micelle-forming pyrazinamide prodrugArch Pharm200633928329010.1002/ardp.200500039
   PubMed Web of Science ®Google Scholar
• AbeylathSCTurosEDickeySLimDVGlyconanobiotics: novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracisBioorg Med Chem2008162412241810.1016/j.bmc.2007.11.05218063370
   PubMed Web of Science ®Google Scholar
• ChengYQuHMaMPolyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro studyEur J Med Chem2007421032103810.1016/j.ejmech.2006.12.03517336426
   PubMed Web of Science ®Google Scholar
• BhadraDBhadraSJainNKPegylated lysine based copolymeric dendritic micelles for solubilization and delivery of artemetherJ Pharm Pharm Sci2005846748216401394
   PubMed Web of Science ®Google Scholar
• IbrahimMTaoZHussainADeciphering the role of Burkholderia cenocepacia membrane proteins in antimicrobial properties of chitosanArch Microbiol201419691610.1007/s00203-013-0936-024213809
   PubMedGoogle Scholar
• LiXChanWKTransport, metabolism and elimination mechanism of anti-HIV agentsAdv Drug Deliv Rev1999398110310.1016/S0169-409X(99)00021-610837769
   PubMed Web of Science ®Google Scholar
• JungSHLimDHJungSHAmphotericin B entrapping lipid nanoparticles and their in vitro and in vivo characteristicsEur J Pharm Sci20093731332010.1016/j.ejps.2009.02.02119491021
   PubMed Web of Science ®Google Scholar
• ChenCZCooperSLInteractions between dendrimer biocides and bacterial membranesBiomaterials2002233359336810.1016/S0142-9612(02)00036-412099278
   PubMed Web of Science ®Google Scholar
• BaloghLSwansonDRTomaliaDAHagnauerGLMcManusATDendrimer-silver complexes and nanocomposites as antimicrobial agentsNano Lett20011182110.1021/nl005502p
   Web of Science ®Google Scholar
• Van de VenHPaulussenCFeijensPBPLGA nanoparticles and nanosuspensions with amphotericin B: potent in vitro and in vivo alternatives to Fungizone and AmBisomeJ Control Rel201216179580310.1016/j.jconrel.2012.05.037
   PubMed Web of Science ®Google Scholar
• LemkeAKiderlenAFPetriBKayserODelivery of amphotericin B nanosuspensions to the brain and determination of activity against Balamuthia mandrillaris amebasNanomedicine2010659760310.1016/j.nano.2009.12.00420060497
   PubMed Web of Science ®Google Scholar
• VandermeulenGRouxhetLArienABrewsterMEPreatVEncapsulation of amphotericin B in poly (ethylene glycol)-block-poly (ε-caprolactone-co-trimrthylene carbonate) polymeric micellesInt J Pharm200630923424010.1016/j.ijpharm.2005.11.03716406402
   PubMed Web of Science ®Google Scholar
• ChoiKCBangGNKimPKimCSongCEAmphotericin B incorporated polymeric micelles composed by poly(D,L-lactide-co-glycolide)/dextran graft copolymerInt J Pharm200835522423010.1016/j.ijpharm.2007.12.01118242900
   PubMed Web of Science ®Google Scholar
• YangZChenMYangMChenJFanWXuPEvaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infectionInt J Nanomed20149327336
   PubMed Web of Science ®Google Scholar
• AngraPKOettingerCBalakrishnaPSD’SouzaMJAmphotericin B microspheres: a therapeutic approach to minimize toxicity while maintaining antifungal activityJ Microencap20092658058710.3109/02652040902797516
   PubMed Web of Science ®Google Scholar
• RizwanSBAssmusDBoehnkeAPreparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccinesEur J Pharm Biopharm201179152210.1016/j.ejpb.2010.12.03421237267
   PubMed Web of Science ®Google Scholar
• WasanEKBartlettKGershkovichPDevelopment and characterization of oral lipid based amphotericin B formulation in enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicansInt J Pharm2009372768410.1016/j.ijpharm.2009.01.00319236839
   PubMed Web of Science ®Google Scholar
• CottleWChaulmoogra oil in leprosyBr Med J18791968969
   PubMedGoogle Scholar
• BergstromSTheorellHDavideHEffect of some fatty acids on the oxygen uptake of Mycobact. Tubercul. Hum. in relation to their bactericidal actionNature194615730610.1038/157306a021017939
   PubMedGoogle Scholar
• WalkerELSweeneyMAThe chemotherapeutics of the chaulmoogric acid series and other fatty acids in leprosy and tuberculosisJ Infect Dis19202623826410.1093/infdis/26.3.238
   Google Scholar
• SaitoHTomiokaHYoneyamaTGrowth of group IV mycobacteria on medium containing various saturated and unsaturated fatty acidsAntimicrob Agents Chemother1984261641696486760
   PubMedGoogle Scholar
• SaitoHTomiokaHSusceptibilities of transparent, opaque, and rough colonial variants of Mycobacterium avium complex to various fatty acidsAntimicrob Agents Chemother1988324004023364959
   PubMedGoogle Scholar
• WilliamsAASugandhiEWMacriRVFalkinhamIII JOGandourRDAntimicrobial activity of long-chain, water-soluble, dendritic tricarboxylato amphiphilesJ Antimicrob Chemother20075945145810.1093/jac/dkl51517242037
   PubMedGoogle Scholar
• FalkinhamIII JOMacriRVMaisuriaBBAntibacterial activities of dendritic amphiphiles against non-tuberculous MycobacteriaTuberculosis20129217318110.1016/j.tube.2011.12.00222209468
   PubMed Web of Science ®Google Scholar
• HussainASinghSKSinghNVermaPRPIn vitro-in vivo in-silico simulation studies of anti-tubercular drugs doped with self-nanoemulsifying drug delivery systemRSC Adv20166931479316110.1039/C6RA14122F
   Web of Science ®Google Scholar
• MullerRHRadtkeMWissingSASolid lipid NPs (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparationsAdv Drug Deliv Rev200254S131S15510.1016/S0169-409X(02)00118-7
   PubMedGoogle Scholar
• GuptaAKCooperEAUpdate in antifungal therapy of dermatophytosisMycopathologia200816635336710.1007/s11046-008-9109-018478357
   PubMed Web of Science ®Google Scholar
• LvQYuAXiYGuangxi Zhai: development and evaluation of penciclovir-loaded nanoparticles for topical deliveryInt J Pharm200937219119810.1016/j.ijpharm.2009.01.01419429280
   PubMed Web of Science ®Google Scholar
• CorwareKHarrisDTeoIRogersMNareshKAccelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acidBiomaterials2011328029803910.1016/j.biomaterials.2011.07.02121807409
   PubMedGoogle Scholar
• ChenHChangXDuDPodophyllotoxin-loaded solid lipid nanoparticles for epidermal targetingJ Control Rel200611029630610.1016/j.jconrel.2005.09.052
   PubMed Web of Science ®Google Scholar
• ManosroiAKongkaneramitAManosroiJStability and transdermal absorption of topical amphotericin B liposome formulationsInt J Pharm200427027928610.1016/j.ijpharm.2003.10.03114726142
   PubMed Web of Science ®Google Scholar
• DeviMKumarMSManadevanNAmphotericin-B loaded vesicular systems for the treatment of topical fungal infectionInt J Recent Adv Pharm Res201143746
   Google Scholar
• VyasSPAgarwalRKatareOPPreparation and in vitro evaluation of liposomal delivery systems for antipsoriatic drug dithranolInt J Pharm2001228435211576767
   PubMedGoogle Scholar
• MugabeCHalwaniMAzghaniAOLafrenieRMOmriAMechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosaAntimicrob Agents Chemother2006502016202210.1128/AAC.01547-0516723560
   PubMed Web of Science ®Google Scholar
• AlipourMHalwaniMOmriASuntresZEAntimicrobial effectiveness of liposomal polymyxin B against resistant gram negative bacterial strainsInt J Pharm200835529329810.1016/j.ijpharm.2007.11.03518164881
   PubMed Web of Science ®Google Scholar
• FischbachMAWalshCTAntibiotics for emerging pathogensScience20093251089109310.1126/science.117666719713519
   PubMed Web of Science ®Google Scholar
• KimHJJonesMNThe delivery of benzyl penicillin to Staphylococcus aureus biofilms by use of liposomesJ Liposome Res20041412313910.1081/LPR-20002988715676122
   PubMed Web of Science ®Google Scholar
• SchumacherIMargalitRLiposome-encapsulated ampicillin: physico-chemical and antibacterial propertiesJ Pharm Sci19978663564110.1021/js95036909145392
   PubMed Web of Science ®Google Scholar
• KadimiUSBalasubramaniamDRGanniURBalaramanMGovindarajuVIn vitro studies on liposomal amphotericin B obtained by supercritical carbon dioxide mediated processNanomedicine2007327328010.1016/j.nano.2007.08.00317962084
   PubMed Web of Science ®Google Scholar
• JainSTiwaryAKJainNKPEGylated elastic liposomal formulation for lymphatic targeting of zidovudineCurr Drug Deliv2008527528118855596
   PubMedGoogle Scholar
• HussainASinghSSharmaDWebsterTJShafaatKFarukAElastic liposomes as novel carrier: recent advances in drug deliveryInt J Nanomed2017125087510810.2147/IJN.S138267
   PubMed Web of Science ®Google Scholar
• KaurLJainSKManhasRKSharmaDNanoethosomal formulation for skin targeting of amphotericin B: an in vitro and in vivo assessmentJ Liposome Res20142529430710.3109/08982104.2014.99567025547800
   PubMed Web of Science ®Google Scholar
• JainSTiwaryAKSapraBJainNKFormulation and evaluation of ethosomes for transdermal delivery of lamivudineAAPS PharmSci-Tech200784E11110.1208/pt0804111
   PubMed Web of Science ®Google Scholar
• RussellADDayMJAntibacterial activity of chlorhexidineJ Hosp Infect19932522923810.1016/0195-6701(93)90109-D7907620
   PubMed Web of Science ®Google Scholar
• HamoudaTMycADonovanBShihAYReuterJDBakerJRJrA novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungiMicrobiol Res20011561710.1078/0944-5013-0006911372645
   PubMed Web of Science ®Google Scholar
• HussainASamadANazishIAhmedFJNanocarrier-based topical drug delivery for an antifungal drugDrug Develop Ind Pharm20144052754110.3109/03639045.2013.771647
   PubMed Web of Science ®Google Scholar
• HussainASinghSWebsterTJAhmadFJNew perspectives in the topical delivery of optimized amphotericin B loaded nanoemulsions using excipients with innate anti-fungal activities: a mechanistic and histopathological investigationNanomedicine2017131117112610.1016/j.nano.2016.12.00228007632
   PubMed Web of Science ®Google Scholar
• DasSSureshPKNanosuspension: a new vehicle for the improvement of the delivery of drug to ocular surface. Application to amphotericin BNanomedicine2011724224720692375
   PubMed Web of Science ®Google Scholar
• PeymanGACharlesHCLiuKRKhoobehiBNiesmanMIntravitreal liposome-encapsulated drugs: a preliminary human reportInt Ophthalmol1988121751823265937
   PubMed Web of Science ®Google Scholar
• ShahSPMisraADevelopment of liposomal amphotericin B dry powder inhaler formulationDrug Deliv20041124725310.1080/1071754049046737515371106
   PubMed Web of Science ®Google Scholar
• ShimizuKOsadaMTakemotoKYamamotoYAsaiTOkuNTemperature dependent transfer of amphotericin B from liposomal formulation of Ambisome to fungal cell membraneJ Control Rel201014120821510.1016/j.jconrel.2009.09.019
   PubMed Web of Science ®Google Scholar
• ImamMHuangZSzokaFJaafariMCharacterizatin of colloidal properties, in vitro antifungal, anti leishmanial and toxicity studies in mice of di-stigma-steryl-hemi-succinoyl-glycero-phosphatidylcholine liposomes-intercalated amphotericin BInt J Pharm201140816317210.1016/j.ijpharm.2011.01.04421277963
   PubMedGoogle Scholar
• GuidelliEJBaffaOClarkeDREnhanced UV emission from Silver/ZnO and Gold/ZnO core-shell nanoparticles: photoluminescence, radiolumi-nescence, and optically stimulated luminescenceSci Rep201551400426365945
   PubMed Web of Science ®Google Scholar
• AhonenMKahruAIvaskAProactive approach for safe use of antimicrobial coatings in healthcare settings: opinion of the COST action network AMiCIInt J Environ Res Public Health20171436610.3390/ijerph14040366
   PubMed Web of Science ®Google Scholar
• GrassGRensingCSoliozMMetallic copper as an antimicrobial surfaceAppl Environ Microbiol2011771541154710.1128/AEM.02766-1021193661
   PubMed Web of Science ®Google Scholar
• ChenXHirtHLiYGorrSUAparicioCAntimicrobial GL13K peptide coatings killed and ruptured the wall of streptococcus gordonii and prevented formation and growth of biofilmsPLoS One20149e11157910.1371/journal.pone.011157925372402
   PubMed Web of Science ®Google Scholar
• DizajSMLotfipourFBarzegar-JalaliMZarrintanMHAdibkiaKAntimicrobial activity of the metals and metal oxide nanoparticlesMater Sci Eng C20144427828410.1016/j.msec.2014.08.031
   PubMed Web of Science ®Google Scholar
• Antimicrobial nanocoatings market – global industry analysis, size, share, growth, trends and forecast 2015–2023Transparency Market Research Available from: http://www.transparencymarke-tresearch.com/antimicrobial-nanocoatingsmarket.htmlAccessed July 19, 2018
   Google Scholar
• FurnoFMorleyKSWongBSilver nanoparticles and polymeric medical devices: a new approach to prevention of infection?J Antimicrob Chemother2004541019102410.1093/jac/dkh47815537697
   PubMed Web of Science ®Google Scholar
• ElliottCThe effects of silver dressings on chronic and burns wound healingBr J Nurs201019S32S3610.12968/bjon.2010.19.Sup5.7770720852480
   PubMedGoogle Scholar
• González-ZornBEscuderoJAEcology of antimicrobial resistance: humans, animals, food and environmentInt Microbiol20121510110910.2436/20.1501.01.17423847814
   PubMedGoogle Scholar
• European CommissionScientific Committee on Emerging and Newly Identified Health RisksBrussels (Belgium)Assessment of the Antibiotic Resistance Effects of Biocides; European Commission2009
   Google Scholar
• LiuJSonshineDAShervaniSHurtRHControlled release of biologically active silver from nanosilver surfacesACS Nano201046903691310.1021/nn102272n20968290
   PubMed Web of Science ®Google Scholar
• PavithraDDobleMBiofilm formation, bacterial adhesion and host response on polymeric implants – issues and preventionBiomed Mater2008303400310.1088/1748-6041/3/3/03400318689922
   PubMed Web of Science ®Google Scholar
• SousaCTeixeiraPOliveiraRInfluence of surface properties on the adhesion of staphylococcus epidermidis to acrylic and siliconeInt J Biomater2009200971801710.1155/2009/71801720126579
   PubMedGoogle Scholar
• BondarenkoOJugansonKIvaskAKasemetsKMortimerMKahruAToxicity of Ag, CuO and ZnO nanoparticles to selected environmentally relevant test organisms and mammalian cells in vitroA Critical Review Arch Toxicol2013871181120010.1007/s00204-013-1079-4
   PubMed Web of Science ®Google Scholar
• IvaskAJugansonKBondarenkoOMechanisms of toxic action of Ag, ZnO and CuO nanoparticles to selected ecotoxico-logical test organisms and mammalian cells in vitro: a comparative reviewNanotoxicology20148577110.3109/17435390.2013.85583124256211
   PubMed Web of Science ®Google Scholar
• FriesRGresslerSSimkóMGazsóAFiedelerUMichaelNNanosilver (Nanotrust Dossier No. 010en)Wien (Austria)Institut für Technikfolgen-Abschätzung (ITA)2010
   Google Scholar
• KäkinenABondarenkoOIvaskAKahruAThe effect of composition of different ecotoxicological test media on free and bioavailable copper from CuSO4 and CuO nanoparticles: comparative evidence from a Cu-selective electrode and a Cu-biosensorSensors201111105021052110.3390/s11111050222346655
   PubMed Web of Science ®Google Scholar
• D’CostaVMKingCEKalanLAntibiotic resistance is ancientNature201147745746110.1038/nature1038821881561
   PubMed Web of Science ®Google Scholar
• AndresenTLBergRHChallengesCFuture directions in nanomedicineJSM Nanotechnol Nanomed2013121013
   Google Scholar
• BettingerCJLangerRBorensteinJTEngineering substrate topography at the micro- and nanoscale to control cell functionAngew Chem Int Ed Engl2009485406541510.1002/anie.20080517919492373
   PubMed Web of Science ®Google Scholar
• PetersenALHansenAEGabizonAAndresenTLLiposome imaging agents in personalized medicineAdv Drug Deliv Rev2012641417143510.1016/j.addr.2012.09.00322982406
   PubMed Web of Science ®Google Scholar
• PrabhakarUMaedaHJainRKSevick-MuracaEMZamboniWFarokhzadOCChallenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncologyCancer Res2013732412241710.1158/0008-5472.CAN-12-456123423979
   PubMed Web of Science ®Google Scholar
• MoghimiSMAndersenAJAhmadvandDMaterial properties in complement activationAdv Drug Deliv Rev2011631000100710.1016/j.addr.2011.06.00221689701
   PubMed Web of Science ®Google Scholar
• SanhaiWRSakamotoJHCanadyRFerrariMSeven challenges for nanomedicineNat Nanotechnol2008324224410.1038/nnano.2008.11418654511
   PubMed Web of Science ®Google Scholar
• HalappanavarSVogelUWallinHYaukCLPromise and peril in nanomedicine: the challenges and needs for integrated systems biology approaches to define health riskWIREs Nanomed Nanobi2018101710.1002/wnan.1465
   Google Scholar
• HareJILammersTAshfordMBPuriSStormGBarrySTChallenges and strategies in anti-cancer nanomedicine development: an industry perspectiveAdv Drug Deliv Rev201610.1016/j.addr.2016.04.025
   PubMed Web of Science ®Google Scholar
• AdlhartCVerranJAzevedoNFSurface modifications for antimicrobial effects in the healthcare setting: a critical overviewJ Hospl Infect20189923924910.1016/j.jhin.2018.01.018
   PubMed Web of Science ®Google Scholar
• VenkatesanJJayakumarRMohandasABhatnagarIKimS-KAntimicrobial activity of chitosan-carbon nanotube hydrogelsMaterials201473946395510.3390/ma705394628788658
   PubMed Web of Science ®Google Scholar
• NeelgundGMOkiALuoZAntimicrobial activity of CdS and Ag2S quantum dots immobilized on poly(amidoamine) grafted carbon nanotubesColloids Surf B Biointerfaces201210021522110.1016/j.colsurfb.2012.05.01222766300
   PubMed Web of Science ®Google Scholar
• AslanSLoebickCZKangSElimelechMPfefferleLDVan TasselPRAntimicrobial biomaterials based on carbon nanotubes dispersed in poly(lactic-co-glycolic acid)Nanoscale201021789179410.1039/c0nr00329h20680202
   PubMed Web of Science ®Google Scholar
• ParkHJangCHChoYBChoiCHAntibacterial effect of tea-tree oil on methicillinresistant Staphylococcus aureus biofilm formation of the tympanostomy tube: an in vitro studyIn Vivo2007211027103018210750
   PubMedGoogle Scholar